Product
Sugammadex
Aliases
Bridion, MK-8616, Sugammadex 100 MG/ML [Bridion], Sugammadex Sodium
32 clinical trials
46 indications
Indication
Neuromuscular BlockadeIndication
Post-operative Nausea and VomitingIndication
Sleeve GastrectomyIndication
TonsillectomyIndication
Postoperative Urinary RetentionIndication
Gallbladder RemovalIndication
SugammadexIndication
NeostigmineIndication
Neuromuscular Blocking AgentsIndication
PharmacodynamicsIndication
HerniaIndication
VentralIndication
IleusIndication
Innate Inflammatory ResponseIndication
OsteoarthritisIndication
hipIndication
Spinal SurgeryIndication
Reversal of Neuromuscular BlockadeIndication
AtelectasisIndication
PostoperativeIndication
Pulmonary FunctionIndication
abnormalIndication
Coronary Artery DiseaseIndication
Valvular Heart DiseaseIndication
Aortic DiseaseIndication
Congestive Heart FailureIndication
AppendicitisIndication
SurgeryIndication
Bowel DysfunctionIndication
Postoperative ComplicationsIndication
ResidualIndication
AnesthesiaIndication
Critical IllnessIndication
Neurologic FindingsIndication
Kidney TransplantIndication
Postoperative Residual CurarizationIndication
Postoperative Residual WeaknessIndication
Head and Neck NeoplasmsIndication
Chronic RhinosinusitisIndication
Chronic Otitis MediaIndication
Neuromuscular BlockIndication
Pulmonary ComplicationsIndication
General AnesthesiaIndication
COVID-19Indication
Respiratory ComplicationIndication
Obstructive Sleep ApneaClinical trial
A Phase 4 Double-blinded, Randomized, Active Comparator-controlled Clinical Trial to Study the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 YearsStatus: Completed, Estimated PCD: 2023-09-21
Clinical trial
Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve GastrectomyStatus: Completed, Estimated PCD: 2019-03-30
Clinical trial
Anesthesia With Neuromuscular Blockade and Reversal With Sugammadex Compared to Anesthesia Without Muscle Relaxation During Pediatric High-Risk Adenotonsillectomy: A Randomized-Controlled TrialStatus: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex in Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2026-09-01
Clinical trial
The Impact of Sugammadex on Ileus After Abdominal Wall ReconstructionStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
The POUR Study: Effects of Neuromuscular Reversal Agents on Postoperative Urinary Retention (POUR) Following Laparoscopic Inguinal Hernia RepairStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
An Observational Study on the Clinical Effect of Sugammadex Sodium (Domestic) for Antagonizing Neuromuscular Blockade After Thoracic SurgeryStatus: Not yet recruiting, Estimated PCD: 2025-01-31
Clinical trial
The Immunomodulatory Effect of Sugammadex After Total Hip Replacement Surgery Under Neuraxial Anaesthesia: a Pilot StudyStatus: Completed, Estimated PCD: 2023-11-23
Clinical trial
A Double-blind, Randomized, Parallel Group Study to Compare Rocuronium Reversal With Sugammadex (Bridion®) Versus Neostigmine/Glycopyrrolate and the Incidence of Urinary Retention After Elective Ambulatory Posterior Lumbar LaminectomyStatus: , Estimated PCD: 2024-08-01
Clinical trial
Effects of Sugammadex and Conventional Reversal on Lung Function in Laparoscopic Abdominal SurgeryStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Sugammadex Titration for Reversal of Rocuronium or Vecuronium in Cardiac Surgery PatientsStatus: Completed, Estimated PCD: 2022-11-10
Clinical trial
Effectiveness of Sugammadex Versus Neostigmine on Neuromuscular Reversal in Pediatric Patients Undergoing Laparoscopic Appendectomy for Acute Appendicitis: A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-10-28
Clinical trial
Evaluation of The Effects of Neostigmine Versus Sugammadex on Renal Functions in Laparoscopic Cholecystecomy A Randomized Controlled StudyStatus: Active (not recruiting), Estimated PCD: 2023-09-01
Clinical trial
An Assessor-blinded, Randomized, Controlled, Single Center, Parallel Design Trial With Patient Masking to Compare Early Postoperative Gastric Emptying Associated With Rocuronium Neuromuscular Reversal With Sugammadex Versus Neostigmine in Adults Undergoing Colon and Rectal SurgeryStatus: Active (not recruiting), Estimated PCD: 2023-07-14
Clinical trial
A Blinded Randomized Study of Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients (≥ 75 Years)Status: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting SurgeryStatus: Completed, Estimated PCD: 2021-07-30
Clinical trial
Effectiveness of Sugammadex Versus Neostigmine on the Reversal of Rocuronium-induced Neuromuscular Blockade in Patients With Myasthenia Gravis After Thoracoscopic Thymectomy: A Multicenter Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2024-10-31
Clinical trial
Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular Block by Neostigmine or Sugammadex: A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Optimizing Post-operative Recovery in Bariatric Patients With Obstructive Sleep Apnea Undergoing Outpatient Surgery: A Comparison of Sugammadex and NeostigmineStatus: Completed, Estimated PCD: 2023-01-04
Clinical trial
A Prospective Randomized Blinded Controlled Trial Comparing Clinical Outcomes in Cardiac Surgical Patients Who Receive Sugammadex vs. PlaceboStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
Effect of Neuromuscular Reversal Agents on Time for Neurological Assessment After Endotracheal Intubation in Critically Ill PatientsStatus: Not yet recruiting, Estimated PCD: 2025-08-14
Clinical trial
A Double-blind, Randomized, Parallel Study to Compare the Efficacy of Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery in Patients With Severe Kidney DysfunctionStatus: Recruiting, Estimated PCD: 2023-09-30
Clinical trial
The Use of Sugammadex as Rescue Therapy Following Inadequate Reversal With NeostigmineStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
A Randomized Clinical Trial to Determine the Effect of Transient Postoperative Urinary Retention Using Sugammadex (4 mg x kg) Versus Glycopyrrolate and Neostigmine (0.01 mg/kg - 50mg/kg) in Patients Undergoing Vaginal Hysterectomies With and Without Pelvic Organ Prolapse Procedures: A Pilot StudyStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Comparison of Efficacy of Sugammadex Versus Neostigmine in Reversing Neuromuscular Blocks in Patients Having Outpatient Endoscopic Retrograde Cholangiopancreatography (ERCP). A Randomized, Double-Blinded TrialStatus: Not yet recruiting, Estimated PCD: 2025-10-31
Clinical trial
Sugammadex Compared With Neostigmine/Glycopyrrolate in Impact of Postoperative Urinary Retention for Head and Neck Surgery Patients With High Risk of DysuriaStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
Diaphragm and Lung Ultrasound After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children Undergoing Surgery : A Randomized Double-blind Controlled TrialStatus: Recruiting, Estimated PCD: 2025-02-15
Clinical trial
Incidence of Postoperative Residual Neuromuscular Blockade in the Era of SugammadexStatus: Recruiting, Estimated PCD: 2023-08-31
Clinical trial
Prevention of Postoperative Events Following Reversal With Sugammadex or NeostigmineStatus: Terminated, Estimated PCD: 2020-04-01
Clinical trial
Randomized Controlled Assessor Blinded Clinical Trial of Sugammadex Versus Neostigmine /Glycopyrrolate for Reversal of Rocuronium Induced Neuromuscular Blockade: Time to Discharge From Post Anesthesia Care Unit and Patient Satisfaction With RecoveryStatus: Completed, Estimated PCD: 2022-03-03
Clinical trial
A Double-blind, Randomized, Parallel Design Study to Compare Postoperative Recovery Between the Sugammadex Group and the Neostigmine Group in Patients After COVID-19.Status: Not yet recruiting, Estimated PCD: 2024-12-25
Clinical trial
A Prospective Digital Quality Improvement Project to Apply Best Clinical Practices to Patients at High Risk of Respiratory ComplicationsStatus: Active (not recruiting), Estimated PCD: 2024-06-01